Can Wonder Eye Drops 'PresVu' Replace Reading Glasses? ENTOD’s CEO Nikkhil K Masurkar Explains

India's drug regulatory body has approved a new treatment designed to eliminate the need for reading glasses for millions suffering from presbyopia. Mumbai-based Entod Pharmaceuticals has developed PresVu Eye Drops, aimed at treating this age-related vision condition, which affects between 1.09 billion and 1.80 billion people worldwide. Presbyopia, a natural part of ageing, typically begins around the mid-40s and progresses until the late 60s, resulting in difficulties focusing on close objects. The Drug Controller General of India (DCGI) granted final approval for PresVu following a recommendation from the Central Drugs Standard Control Organisation's Subject Expert Committee. Claimed to be the first eye drop of its kind in India, PresVu is designed specifically for individuals over 40 who seek to reduce their reliance on reading glasses. Its proprietary formula not only aims to eliminate the need for eyewear but also lubricates the eyes, enhancing overall comfort. Key to its efficacy is an advanced dynamic buffer technology that allows PresVu to adapt quickly to tear pH, ensuring consistent performance and safety for long-term use. This feature is particularly important as the drops are intended for extended application, allowing users to benefit from improved vision without surgical intervention. Watch Exclusive Conversation With Nikkhil K Masurkar, CEO of ENTOD.